Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular cardiovascular imaging.

Lawrence W Dobrucki1, Albert J Sinusas

  • 1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, PO Box 208017, 3FMP, New Haven, CT 06520-8017, USA.

Current Cardiology Reports
|February 19, 2005
PubMed
Summary

Molecular imaging advances, including micro single-photon emission computed tomography (SPECT) and micro positron emission tomography (PET), enhance cardiovascular disease diagnosis. These techniques improve risk stratification and guide therapeutic interventions for ischemic heart disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a novel protocol for processing fluorescent microspheres used in quantifying tissue perfusion.

Sensing and Bio-Sensing Research·2026
Same author

Exercise Training Stimulates the Release of Glutathione Peroxidase 1 (GPX1)-Enriched Extracellular Vesicles That Promote Angiogenesis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Patients' pain experience in claudication: Biopsychosocial correlates of frequency, intensity, sleep interference, and chronic pain.

The journal of pain·2026
Same author

Importance of Understanding the Kinetics of Cardiac Amyloid Radionuclide Imaging.

Circulation. Cardiovascular imaging·2026
Same author

Coronary microvascular dysfunction in systemic sclerosis: insights from PET-derived myocardial flow reserve.

Rheumatology (Oxford, England)·2026
Same author

Assessing Coronary Calcium Thresholds on Attenuation-Correction CT With Myocardial Perfusion Imaging Equating to Secondary Prevention.

JACC. Advances·2026

Area of Science:

  • Nuclear medicine and molecular imaging.
  • Cardiovascular disease research.
  • Biomedical engineering and instrumentation.

Background:

  • Radionuclide imaging is crucial for cardiovascular disease detection, risk stratification, and prognostication.
  • Advances in molecular biology necessitate novel diagnostic imaging approaches for new therapeutic interventions.
  • Development of advanced instrumentation is essential for noninvasive, targeted radiotracer-based strategies.

Purpose of the Study:

  • To provide an overview of molecular imaging in cardiovascular disease.
  • To review basic concepts, technological advancements, and applications of molecular imaging.
  • To highlight the role of SPECT and PET radiotracers in evaluating ischemic heart disease and therapeutic interventions.

Main Methods:

Related Experiment Videos

  • Review of current literature on molecular imaging techniques.
  • Focus on advancements in micro single-photon emission computed tomography (micro-SPECT) and micro positron emission tomography (micro-PET) hybrid systems.
  • Discussion of radiotracer development and application in cardiovascular imaging.

Main Results:

  • Technological progress has enabled dedicated micro-SPECT and micro-PET systems for small animal imaging.
  • These systems facilitate detailed molecular imaging of cardiovascular structures and functions.
  • SPECT and PET radiotracers show significant potential in evaluating ischemic heart disease and monitoring therapeutic responses.

Conclusions:

  • Molecular imaging, particularly using SPECT and PET, is a rapidly evolving field with significant implications for cardiovascular medicine.
  • Technological innovations are crucial for advancing noninvasive diagnostic and prognostic capabilities.
  • Continued development of radiotracers and imaging systems will enhance the evaluation of ischemic heart disease and guide novel therapeutic strategies.